The Washington State Liquor and Cannabis Board (WSLCB) is the primary adult use cannabis regulatory authority in the State of Washington. The executive agency, which also regulates alcohol, tobacco, and vapor products in Washington state, is overseen by a three member board appointed by the Governor to six-year terms. The Board holds regular public meetings and work sessions with stakeholders, makes policy and budget decisions, and adjudicates contested license applications and enforcement actions on licensees. Board members are also responsible for hiring the agency's Director, who manages day-to-day operations.
Washington State Liquor and Cannabis Board
(WSLCB)
- WSLCB - Alcohol Advisory Council
- WSLCB - Board Caucus
- WSLCB - Board Meeting
- WSLCB - Cannabis Advisory Council
- WSLCB - COVID - Incident Command
- WSLCB - COVID - Legal/Policy/Rules Meeting
- WSLCB - Deliberative Dialogue
- WSLCB - Engagement
- WSLCB - Engagement - BIPOC
- WSLCB - Executive Management Team
- WSLCB - Focus Group
- WSLCB - Integrator Work Session
- WSLCB - Internal
- WSLCB - Listen and Learn Forum
- WSLCB - Special Board Caucus
- WSLCB - Special Board Meeting
- WSLCB - Traceability Advisory Committee
- WSLCB - Tribal Advisory Council
- WSLCB - Webinar
- WSLCB - Work Group - Cannabis Penalties
- WSLCB - Work Group - Cannabis Potency Tax
- WSLCB - Work Group - Healthy Youth Survey
- WSLCB - Work Group - Traceability 2.0
- WSLCB - Work Group - True Party of Interest
- WSLCB - Work Group - Voluntary Compliance Program
- WSLCB - World Cafe
Structural Relationships
-
Washington State Office of the Governor
(WA Governor) -
Washington State Liquor and Cannabis Board
(WSLCB) -
Washington State Task Force on Marijuana OdorInactive
(WA Task Force on Marijuana Odor) -
WSLCB Cannabinoid Science Work GroupInactive
(WSLCB - Work Group - Cannabinoid Science) -
WSLCB Quality Control Standards Work Group
(WSLCB - Work Group - QC Standards)
Information Set
-
WSLCB - Active Rulemaking Projects
[ InfoSet ]
- WSLCB - Employee Stock Ownership Plans - Rulemaking Project (October 9, 2024) [ InfoSet ]
- WSLCB - Identification Reform - Rulemaking Project (October 9, 2024) [ InfoSet ]
- WSLCB - Lab Authority Transfer - Rulemaking Project (July 17, 2024) [ InfoSet ]
- WSLCB - Minors on Wholesale Licensed Premises - Rulemaking Project (February 28, 2024) [ InfoSet ]
- WSLCB - Product Samples - Rulemaking Project (March 1, 2023) [ InfoSet ]
- WSLCB - SB 5080 Implementation - Rulemaking Project (November 8, 2023) [ InfoSet ]
- WSLCB - SB 5367 Implementation - Rulemaking Project (June 21, 2023) [ InfoSet ]
- WSLCB - SB 5376 Implementation - Rulemaking Project (May 22, 2024) [ InfoSet ]
-
WSLCB - Active Rulemaking Petitions
[ InfoSet ]
- WSLCB - Batch Tracking - Rulemaking Petition (August 29, 2023) [ InfoSet ]
- WSLCB - Biometric Identification - Rulemaking Petition (May 17, 2023) [ InfoSet ]
- WSLCB - Captive Insurance Companies - Rulemaking Petition (October 31, 2024) [ InfoSet ]
- WSLCB - COA Expiration Dates - Rulemaking Petition (October 30, 2023) [ InfoSet ]
- WSLCB - Employee Stock Ownership Plans - Rulemaking Petition (Mar 26, 2024) [ InfoSet ]
- WSLCB - Harvest or Processing Date - Rulemaking Petition (January 26, 2024) [ InfoSet ]
- WSLCB - Heavy Metals Testing - Rulemaking Petition (Dec 8, 2023) [ InfoSet ]
- WSLCB - Payment Flexibility - Rulemaking Petition (October 14, 2024) [ InfoSet ]
- WSLCB - Social Equity License Mobility - Rulemaking Petition (May 17, 2024) [ InfoSet ]
- WSLCB - Social Equity License Mobility - Rulemaking Petition (June 17, 2024) [ InfoSet ]
- WSLCB - Traceability Platform - Rulemaking Petition (October 2, 2024) [ InfoSet ]
- WSLCB - Transporter Fulfillment Hub - Rulemaking Petition (July 16, 2024) [ InfoSet ]
Observations
WA SECTF - Work Group - Licensing - Public Meeting
(March 17, 2022) - Summary
- USA - Washington
- Washington State Legislative Task Force on Social Equity in Cannabis Licensing Work Group (WA SECTF - Work Group - Licensing)
A Denver cannabis club owner and a consumer representative shared ideas and policies on social use of cannabis before the group discussed what might work in Washington.
The Week Ahead
(March 21, 2022)
WSLCB staff would accept feedback on the upcoming social equity retail licensure window and the Cannabis Alliance planned to host leading legislators to discuss what happened in 2022.
WSLCB - Board Caucus
(March 15, 2022) - Summary
The caucus meeting touched on existing rulemaking; a proposal to label cannabis vapor cartridges; the highs and lows of the legislative session; and a newly appointed board member.
WA Governor - Bill Action
(March 11, 2022) - HB 1210
The governor acknowledged the racist legacy of using the term ‘marijuana’ in reference to the plant before signing a law to use the word ‘cannabis’ in state statute and rules instead.
The Week Ahead
(March 14, 2022)
Three cannabis-related bills were passed by the legislature in 2022—out of 31 introduced—yet WSLCB and social equity task force work continued nonetheless.
WA House - Session - Afternoon
(March 4, 2022) - SB 5796 - Second and Third Reading
Two changes to a striking amendment were debated—one for quite some time—before representatives passed a bill modifying intended cannabis tax revenue appropriations.
WSLCB - Board Caucus
(March 8, 2022) - Summary
After rulemaking and legislative updates, Chair David Postman had a lot to say about committee changes to the last moving cannabinoid regulation and enforcement bill - none of it flattering.
WA Senate WM - Committee Meeting
(March 7, 2022) - SB 5983 - Executive Session
Given two proposed substitutes on a bill to regulate cannabinoids, almost the entire committee voted for a more limited version to get some cannabinoid products off the shelves and study the issues.
The Week Ahead
(March 7, 2022)
In the final week of a contentious short session, legislators would have to sprint to pass SB 5983, a bill to protect public health but also fundamentally restructure cannabis law.
WA Senate WM - Committee Meeting
(March 5, 2022) - SB 5983 - Public Hearing
A last-minute hearing on a repackaged bill to regulate synthesized cannabinoids revealed shared public health concerns but testimony otherwise remained just as sharply divided.